NEOG — NEOGEN CORP
—
Nasdaq ·
Health Care ·
Life Sciences Tools & Services ·
CIK 711377 ·
Last close
$11.85
Market Cap
$2.58B
52W High
$14.26
52W Low
$5.37
ADV30
4,502,928
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| May 2026 | 225,300,000 | 107,800,000 | 3,100,000 | -11,300,000 | 3,346,000,000 | 185,500,000 | 1,253,100,000 |
| Feb 2026 | 211,200,000 | 99,000,000 | -3,300,000 | -17,000,000 | 3,359,000,000 | 159,900,000 | 1,256,600,000 |
| Nov 2025 | 224,691,000 | 106,684,000 | -5,377,000 | -15,924,000 | 3,359,953,000 | 145,340,000 | 1,255,465,000 |
| Aug 2025 | 209,189,000 | 94,970,000 | -16,091,000 | 36,338,000 | 3,378,156,000 | 138,883,000 | 1,259,507,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$83,200,000
Investing CF
$70,500,000
Financing CF
$-99,400,000
CapEx
$-51,300,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.80
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-544,300,000
Inventory
$144,300,000
Receivables
$146,800,000
ST Investments
$0
EBIT TTM
$50,134,000
Pretax Income TTM
$-8,956,000
Interest Exp TTM
$59,090,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$870,400,000
EBITDA
$94,700,000
Free Cash Flow
$69,500,000
Enterprise Value
$3,195,799,808
Total Cash
$185,500,000
Total Debt
$812,600,000
Shares Out
218,106,005
Trailing EPS
$-0.04
Book Value
$9.61
ROE
-0.4%
ROA
-0.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| May 2026 | 870,400,000 | -21,600,000 | -7,900,000 | 3,346,000,000 | 1,253,100,000 | 2,092,900,000 | 83,200,000 |
| May 2025 | 894,700,000 | -1,700,000 | -1,092,000,000 | 3,443,800,000 | 1,372,600,000 | 2,071,200,000 | 58,200,000 |
| May 2024 | 924,200,000 | 58,600,000 | -9,400,000 | 4,548,833,000 | 1,404,691,000 | 3,144,142,000 | 35,300,000 |
| May 2023 | 822,447,000 | 37,515,000 | -22,870,000 | 4,554,432,000 | 1,420,215,000 | 3,134,217,000 | 41,028,000 |
TTM Snapshot
Revenues TTM
$870,539,000
NetIncome TTM
$-608,782,000
OpCashFlow TTM
—
Assets (Latest)
$3,359,000,000
Forward EPS
$0.38
Max Pain — expiry 2026-10-16
max pain strike: $12.50 · spot: $11.85 · call oi: 10,902 · put oi: 7,529
Expected Move to 2026-10-16:
±$0.85
(7.17%) —
implied range
$11.00 –
$12.70
· ATM straddle on $12.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | $2.35B | $29.89 | — |
| NTLA | Intellia Therapeutics, Inc. | $1.83B | $13.07 | — |
| ABSI | Absci Corp | $1.74B | $10.16 | — |
| LNTH | Lantheus Holdings, Inc. | $6.54B | $100.15 | — |
| QDEL | QuidelOrtho Corp | $920.28M | $13.42 | — |
News headlines (Yahoo Finance, 1h cache)
Neogen (NEOG) Received An FDA Warning Over Contaminated Veterinary Product
2026-10-08 16:19 · Yahoo
The 5 Most Interesting Analyst Questions From Neogen’s Q3 Earnings Call
2026-10-08 07:20 · Yahoo
Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
2026-10-08 02:02 · Yahoo
Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day
2026-10-07 22:33 · Yahoo
Why Are Neogen (NEOG) Shares Soaring Today
2026-10-07 18:56 · Yahoo
Neogen (NEOG) Q1 2027 Earnings Call Transcript
2026-10-07 15:58 · Yahoo
This Food-Safety Stock Is Dropping After Earnings Beat. Growth Problems Are Lurking.
2026-10-07 15:04 · Yahoo
Neogen Soars 4% as Q1 Revenue Beat and Raised Guidance Show “Encouraging Progress”
2026-10-07 13:34 · Yahoo
Neogen Corporation Q1 2027 Earnings Call Summary
2026-10-07 12:30 · Yahoo
What Neogen (NEOG) Said on Its Q1 Earnings Call
2026-10-06 23:02 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.